Needham Maintains Buy on Hinge Health, Raises Price Target to $97
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $76 to $97.
Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $76 to $97.